“This product is going from Sarasota, really all over the world," Patti Norris, Biolife's director business development, told the news organization. "We've sent it to be used in Liberia at this point, but our plans are to really get it anywhere it's needed," she said. “Right now it's being used at Texas Health Presbytarian in Texas, where the first patient was diagnosed with Ebola on U.S. soil.”
The product ( a powder) stops the bleeding and seals the wound after pressure is applied by forming an instant scab. “That scab is particularly valuable in the case of Ebola or any other injury, because it stays in place until the wound heals," noted Andrew McFall, Biolife VP marketing. "So you're avoiding the use of bloody bandages and having to constantly maintain a bleeding wound.”